Zobrazeno 1 - 10
of 51
pro vyhledávání: '"T I Kotkina"'
Autor:
I E Chazova, L G Ratova, I P Kolos, T I Kotkina, S Yu Martsevich, O M Moiseeva, M P Kozyreva, N A Dmitrieva, Yu A Semenova, G F Andreeva, V P Voronina, Yu V Lukina, P Yu Ivanenkova, A A Serazhim, N A Fel'dsherova
Publikováno v:
Системные гипертензии, Vol 2, Iss 1, Pp 3-6 (2005)
Проблема адекватного лечения больных артериальной гипертонией (АГ) будет оставаться актуальной еще в течение длительного времени. В по
Externí odkaz:
https://doaj.org/article/11c3138c16a14b78a0893dc8dac44e6e
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 44-51 (2019)
Aim. To study the possibility of reducing the risk of intraoperative cardiac damage and 4a type myocardial infarction (MI) by administering the oral nicorandil in patients with a stable form of coronary artery disease (CAD) before planned percutaneou
Externí odkaz:
https://doaj.org/article/e1fbabc9074b42eebbbf12b9bb04c31b
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 2, Pp 191-198 (2020)
Aim. To study nicorandil prescription effects before elective percutaneous coronary intervention (PCI) to prevent myocardial injury and 4a type acute myocardial infarction (MI, primary endpoint) and cardiovascular events (CVE) in the first year after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660cb95d792a636c01a3b1580137f972
https://doi.org/10.20996/1819-6446-2020-04-05
https://doi.org/10.20996/1819-6446-2020-04-05
Autor:
O. O. Shakhmatova, A. L. Komarov, D. V. Rebrikov, M. A. Turchaninova, T. I. Kotkina, A. V. Bolvacheva, A. D. Deev, A. B. Dobrovolsky, E. V. Titaeva, E. A. Panchenko
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 9, Iss 4, Pp 49-58 (2010)
Aim. To identify the factors determining homocysteine (HMC) levels in Russian patients with stable coronary heart disease (CHD). Material and methods. The study included 506 patients (388 men; mean age 59,4±12,2 years) with stable CHD. Classical ris
Externí odkaz:
https://doaj.org/article/3fd941d2f5c246d29eaf20407799db75
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 44-51 (2019)
Aim. To study the possibility of reducing the risk of intraoperative cardiac damage and 4a type myocardial infarction (MI) by administering the oral nicorandil in patients with a stable form of coronary artery disease (CAD) before planned percutaneou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6beae31b4410fd856d17141ced3c84d
https://russjcardiol.elpub.ru/jour/article/view/3323
https://russjcardiol.elpub.ru/jour/article/view/3323
Autor:
E. A. Tabakyan, S. A. Partigulov, M. G., Lepilin, I. V. Burmistrova, V. D. Vodyasov, T. I. Kotkina, V. N. Titov
Publikováno v:
Общая реаниматология, Vol 9, Iss 1 (2013)
Objective: to analyze the informative value of new methods for the early diagnosis of acute kidney injury (AKI) to determine treatment policy after heart surgery under extracorporeal circulation (EC). Subjects and methods. Patients of both sexes were
Externí odkaz:
https://doaj.org/article/fd8e4f4c55ca4885b930826f15f016c0
Autor:
R.V Gostishev, T.V Soboleva, T. I. Kotkina, Yu. A. Karpov, A.N. Rogoza, A. N. Samko, G.N. Soboleva
Publikováno v:
European Heart Journal. 41
Introduction Elective percutaneous coronary intervention (PCI) is accompanied by intraoperative ischemic myocardial injury (IIMI) up to 30% of the cases despite successfully performed procedure. Pharmacological preconditioning can prevent IIMI; Nicor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33f75eb21fc9b29a12444e55b676eed3
https://doi.org/10.1093/ehjci/ehaa946.1463
https://doi.org/10.1093/ehjci/ehaa946.1463
Autor:
T. A. Ilyushenko, Denis V. Rebrikov, A. L. Komarov, O. O. Shahmatova, E. P. Panchenko, Alexander D. Deev, T. I. Kotkina, D. Yu. Trophimov
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 7, Iss 4, Pp 409-425 (2016)
Aim. To estimate influence of thrombosis associated genetic factors on cardiovascular complications (CVC) occurrence in patients with stable ischemic heart disease (IHD) on the base of 5-year prospective survey. Material and methods. A total of 503 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c2c9e632fa762b9370e46ece6d63f47
https://www.rpcardio.com/jour/article/view/848
https://www.rpcardio.com/jour/article/view/848
Autor:
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 7, Iss 5, Pp 524-535 (2016)
Background. Vitamins В6 В12 and folic acid (FA) therapy to reduce cardiovascular risk appears to be unreasonable. Negative results of recent large-scale trials might be due to high daily doses of the vitamins and widespread FA fortification program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08788c4775c85063fa7c9f6c8e3eb5e8
https://www.rpcardio.com/jour/article/view/891
https://www.rpcardio.com/jour/article/view/891
Autor:
E. D. Ovchinnikova, I. Yu. Adamova, S.N. Pokrovsky, P. A. Levashov, O. I. Afanasjeva, T. I. Kotkina, A. A. Az’muko, M. I. Afanasjeva, D. A. Fried
Publikováno v:
Russian Journal of Bioorganic Chemistry. 41:494-499
Affinity haemoadsorbents based on WY, WTY, WNY ligands and polysaccharide matrix were developed for the human immunoglobulin G binding. The characteristics of new sorbents such as the binding of total IgG and binding of IgG subclasses were compared.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25245d030210a742714f348162d58d7b
https://doi.org/10.1134/s1068162015040081
https://doi.org/10.1134/s1068162015040081